Skip to main content

Institutional intelligence for Aarti Pharmalabs Limited

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters42.86%
  • FII8.17%
  • Mutual Funds0.79%
  • DII (ex-MF)6.43%
  • Retail & others41.75%
  • 1% Club 1.10%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

42.86%11 named
HolderStakeSharesValue (₹ Cr)
4.23%38,34,404₹269.1 Cr
3.53%32,04,310₹224.8 Cr
3.30%29,92,950₹210.0 Cr
3.13%28,41,504₹199.4 Cr
3.11%28,15,612₹197.6 Cr
3.07%27,84,094₹195.4 Cr
2.80%25,42,750₹178.4 Cr
2.69%24,35,830₹170.9 Cr
1.57%14,25,900₹100.1 Cr
1.44%13,08,496₹91.8 Cr
1.24%11,22,487₹78.8 Cr

Retail & others

Holders below 1% disclosure threshold and public non-institutions

41.75%

SEBI requires naming only shareholders with ≥1% stake. The remaining 41.75% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

FII / FPI

Foreign portfolio investors

8.17%1 named
HolderStakeSharesValue (₹ Cr)
2.16%19,55,751₹137.2 Cr

DII (other)

Insurance, banks, AIF, other domestic institutions

6.43%1 named
HolderStakeSharesValue (₹ Cr)
Tracked as LIC5.27%47,82,452₹335.6 Cr

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

1.10%1 named
HolderStakeSharesValue (₹ Cr)
1.10%9,97,427₹70.0 Cr

Mutual Funds

Domestic mutual funds & UTI

0.79%No names

No named holders ≥1% in this bucket.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.